Ampio announces enrolment completion for intravenous Covid-19 clinical trial

This article was originally published here

Enrollment has been completed for the AmpionTM Phase I US based clinical trial for IV treatment of COVID-19 patients requiring supplemental oxygen. The final results from the 5-day

The post Ampio announces enrolment completion for intravenous Covid-19 clinical trial appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply